Table 2.
Cardiac output meaurements in patients treated for cardiovascular instability.
| Study | No. | Gestation | Agents | RVO | LVO | SVC | Outcome |
|---|---|---|---|---|---|---|---|
| Roze | 20 | <32 weeks | Dop Dob | n | y | n | Dop: Reduction |
| Chatterjee | 20 | <32 weeks | Dop Dob | y | y | n | No change |
| Phillipos | 20 | >1750 g | Dop Epi | y | y | n | Dop: Reduction |
| Osborn | 40 | <30 weeks | Dop Dob | y | n | y | Dop: Reduction |
| Lundstrum | 36 | <33 weeks | Dop Vol | n | y | n | Dop: Increase |
| Paradisis | 90 | <30 weeks | Mil Pla | y | n | y | No change |
Dop: Dopamine; Dob: Dobutamine; Epi: Epinephrine; Mil: Milrinone; Vol: Volume; Pla: Placebo.